UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 310

Sortiert nach

Technology transfer hub for pandemic influenza vaccine

Vaccine, 2009-01, Vol.27 (5), p.631-632

2009

Volltextzugriff (PDF)

Mucosal immunity and tolerance: relevance to vaccine development

Immunological reviews, 1999-08, Vol.170 (1), p.197-222

1999

Volltextzugriff (PDF)

Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26–27 April 2004, Bangkok, Thailand

Vaccine, 2005-04, Vol.23 (21), p.2689-2695

2005

Volltextzugriff (PDF)

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

Proceedings of the National Academy of Sciences - PNAS, 1991-01, Vol.88 (2), p.542-546

1991

Volltextzugriff (PDF)

Malaria vaccine development: progress and challenges

Current molecular medicine, 2006-03, Vol.6 (2), p.231

2006

Volltextzugriff (PDF)

HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines

Archives of virology, 2004-02, Vol.149 (2), p.323-336

2004

Volltextzugriff (PDF)

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

Nature (London), 1991-12, Vol.354 (6354), p.520-522

1991

Volltextzugriff (PDF)

Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins

Journal of Virology, 2003-05, Vol.77 (9), p.5401-5414

2003

Volltextzugriff (PDF)

Dichotomy of protective cellular immune responses to human visceral leishmaniasis

Clinical and experimental immunology, 2005-05, Vol.140 (2), p.349-353

2005

Volltextzugriff (PDF)

Vaccine Protection of Chimpanzees Against Challenge with HIV-1-Infected Peripheral Blood Mononuclear Cells

Science (American Association for the Advancement of Science), 1992-06, Vol.256 (5064), p.1687-1690

1992

Volltextzugriff (PDF)

Focus: Meningococcal meningitis

Nature reviews. Microbiology, 2005-01, Vol.3 (1), p.10-11

2005

Volltextzugriff (PDF)

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Cancer Immunology, Immunotherapy, 2000, Vol.48 (10), p.588-594

2000

Volltextzugriff (PDF)

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1

Journal of Virology, 1995-10, Vol.69 (10), p.6239-6248

1995

Volltextzugriff (PDF)

Ethical considerations related to the provision of care and treatment in vaccine trials

Vaccine, 2007-06, Vol.25 (26), p.4863-4874

2007

Volltextzugriff (PDF)

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

Nature (London), 1984-11, Vol.312 (5990), p.163-166

1984

Volltextzugriff (PDF)

Vaccination Against Tumor Cells Expressing Breast Cancer Epithelial Tumor Antigen

Proceedings of the National Academy of Sciences - PNAS, 1990-12, Vol.87 (23), p.9498-9502

1990

Volltextzugriff (PDF)

Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic

AIDS research and human retroviruses, 1993-10, Vol.9 (10), p.997-1006

1993

Volltextzugriff (PDF)

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

Nature (London), 1987-11, Vol.330 (6145), p.266-269

1987

Volltextzugriff (PDF)

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells

AIDS research and human retroviruses, 1993-08, Vol.9 (8), p.761-773

1993

Volltextzugriff (PDF)

Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa

Journal of Virology, 1996-06, Vol.70 (6), p.3331-3338

1996

Volltextzugriff (PDF)

Memory Cytotoxic T Lymphocyte Responses in Human Immunodeficiency Virus Type 1 (HIV-1)-Negative Volunteers Immunized with a Recombinant Canarypox Expressing gp160 of HIV-1 and Boosted with a Recombinant gp160

The Journal of infectious diseases, 1996-10, Vol.174 (4), p.734-738

1996

Volltextzugriff (PDF)

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus

Nature (London), 1986-07, Vol.322 (6077), p.373-375

1986

Volltextzugriff (PDF)

Mutational analysis of the HIV nef protein

Virology (New York, N.Y.), 1990-06, Vol.176 (2), p.413-425

1990

Volltextzugriff (PDF)

A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein

Journal of Virology, 1991-03, Vol.65 (3), p.1325-1331

1991

Volltextzugriff (PDF)

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

The New England journal of medicine, 2016-04, Vol.374 (17), p.1647-1660

2016

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(147)
Science & Technology
(138)
Life Sciences & Biomedicine
(128)
Animals
(114)
Biological And Medical Sciences
(98)
Fundamental And Applied Biological Sciences. Psychology
(71)
Virology
(67)
Aids/hiv
(62)
Microbiology
(53)
Female
(49)
Immunology
(48)
Male
(45)
Molecular Sequence Data
(44)
Infectious Diseases
(38)
Amino Acid Sequence
(34)
Medical Sciences
(33)
Vaccinia Virus
(31)
Adult
(30)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(30)
Mice
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Technology transfer hub for pandemic influenza vaccine

Mucosal immunity and tolerance: relevance to vaccine development

Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26–27 April 2004, Bangkok, Thailand

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

Malaria vaccine development: progress and challenges

HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins

Dichotomy of protective cellular immune responses to human visceral leishmaniasis

Vaccine Protection of Chimpanzees Against Challenge with HIV-1-Infected Peripheral Blood Mononuclear Cells

Focus: Meningococcal meningitis

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1

Ethical considerations related to the provision of care and treatment in vaccine trials

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

Vaccination Against Tumor Cells Expressing Breast Cancer Epithelial Tumor Antigen

Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells

Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa

Memory Cytotoxic T Lymphocyte Responses in Human Immunodeficiency Virus Type 1 (HIV-1)-Negative Volunteers Immunized with a Recombinant Canarypox Expressing gp160 of HIV-1 and Boosted with a Recombinant gp160

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus

Mutational analysis of the HIV nef protein

A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Suchergebnisse filtern